Hem › Major depression › Kalifornien › Orange
Kliniska studier för Major depression i Orange, CA
13 studier för Major depression söker deltagare vid platser i och runt Orange (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
RekryterarFas 3
- NRC Research Institute, Orange
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
RekryterarFas 2
- Nrc Research Institute, Orange
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RekryterarFas 3
- ATP Clinical Research, Orange
- NRC Research Institute, Orange
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
RekryterarFas 3
- Vanda Investigational Site, Orange
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RekryterarFas 4
- Neurocrine Clinical Site, Orange
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
RekryterarFas 2
- PNS Clinical Research LLC dba ATP Clinical Research, Orange
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
RekryterarFas 3
- ATP Clinical Research Orange County, Orange
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
RekryterarFas 3
- ATP Clinical Research, Orange
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
RekryterarFas 3
- Atp Clinical Research, Orange
- Nrc Research Institute, Orange
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RekryterarFas 3
- Neurocrine Clinical Site, Orange
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RekryterarFas 3
- Neurocrine Clinical Site, Orange
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
RekryterarFas 2
- Autobahn Site #152, Orange
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RekryterarFas 3
- Neurocrine Clinical Site, Orange
Major depression-studier i andra städer
- New York City, NY37 studier
- Boston, MA31 studier
- Atlanta, GA25 studier
- Philadelphia, PA23 studier
- Orlando, FL19 studier
- Miami, FL18 studier
- Chicago, IL17 studier
- Tampa, FL17 studier
- Houston, TX16 studier
- San Diego, CA16 studier
- Little Rock, AR14 studier
- Austin, TX13 studier
Andra studier i Orange
- Icke-småcellig lungcancer25 studier
- Metastaserande cancer20 studier
- Kolorektal cancer16 studier
- Äggstockscancer16 studier
- Bukspottkörtelcancer15 studier
- Bröstcancer14 studier
- Lungcancer14 studier
- Prostatacancer14 studier
- Levercancer (hepatocellulärt karcinom)14 studier
- Melanom14 studier
- Akut myeloid leukemi13 studier
- Cancer (alla typer)13 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.